View in EDS

Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma.
Authors: Ono A; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Hayes CN; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Kawaoka T; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Tsuge M; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Liver Center, Hiroshima University Hospital, Hiroshima, Japan., Oka S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Source: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2026 Apr 30; Vol. 17 (2), pp. 114. Date of Electronic Publication: 2026 Apr 28.
Publication Type: Editorial; Comment
Journal Info: Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42169919
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ono+A%22">Ono A</searchLink>; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Hayes+CN%22">Hayes CN</searchLink>; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Kawaoka+T%22">Kawaoka T</searchLink>; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuge+M%22">Tsuge M</searchLink>; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Liver Center, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Oka+S%22">Oka S</searchLink>; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101557751%22">Journal of gastrointestinal oncology</searchLink> [J Gastrointest Oncol] 2026 Apr 30; Vol. 17 (2), pp. 114. <i>Date of Electronic Publication: </i>2026 Apr 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Group%22">AME Publishing Group </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101557751 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2078-6891 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220786891%22">20786891 </searchLink><i>NLM ISO Abbreviation: </i>J Gastrointest Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42169919
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/jgo-2025-aw-857
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 114
    Titles:
      – TitleFull: Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ono A
      – PersonEntity:
          Name:
            NameFull: Hayes CN
      – PersonEntity:
          Name:
            NameFull: Kawaoka T
      – PersonEntity:
          Name:
            NameFull: Tsuge M
      – PersonEntity:
          Name:
            NameFull: Oka S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 04
              Text: 2026 Apr 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2078-6891
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of gastrointestinal oncology
              Type: main
ResultId 1